QuiVad

Home / Funds / Mangrove Partners

Mangrove Partners

The short positions this fund discloses today, across every market.

Open short positions, the heaviest first.
IssuerMarket% of capitalSince
Aeluma, INC.Germany1.35%July 21, 2026
Iperionx LtdGermany1.06%April 17, 2025

History of disclosures

22 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
July 21, 2026Aeluma, INC.Germany1.35%still open
April 17, 2025Iperionx LtdGermany1.06%still open
March 14, 2022Mycronic AB (publ)Sweden0.00%still open
October 22, 2021Oncopeptides ABSweden0.00%still open
October 11, 2021Oncopeptides ABSweden0.73%still open
October 8, 2021Oncopeptides ABSweden0.93%still open
September 17, 2021Oncopeptides ABSweden1.10%still open
September 13, 2021Oncopeptides ABSweden1.00%still open
September 8, 2021Oncopeptides ABSweden0.96%still open
August 4, 2021Oncopeptides ABSweden0.84%still open
July 13, 2021Oncopeptides ABSweden0.79%still open
July 9, 2021Oncopeptides ABSweden0.58%still open
February 3, 2021Mycronic AB (publ)Sweden0.57%still open
January 28, 2021Mycronic AB (publ)Sweden0.76%still open
January 21, 2021Mycronic AB (publ)Sweden0.82%still open
January 19, 2021Mycronic AB (publ)Sweden0.95%still open
January 18, 2021Mycronic AB (publ)Sweden1.08%still open
December 18, 2020Mycronic AB (publ)Sweden1.18%still open
December 15, 2020Mycronic AB (publ)Sweden1.27%still open
December 9, 2020Mycronic AB (publ)Sweden1.39%still open
July 22, 2020Mycronic AB (publ)Sweden1.48%still open
May 5, 2020Mycronic AB (publ)Sweden1.59%still open

The funds short on the same companies